v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ (20,817) $ 523
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 10,576 18,259
Impairment expense 0 8,448
Loss (gain) on derivative instruments 36,813 (7,845)
Cash settlements (paid) received on expired derivative instruments (16,169) 5,284
Cash settlements received (paid) on terminated derivative instruments (350) 0
Deferred income tax expense (benefit) (5,659) (118)
Accretion of asset retirement obligations 2,518 4,393
Gain on sale of properties (1,737) 0
Share-based compensation (see Note 11) 3,297 3,880
Settlement of asset retirement obligations (60) (525)
Amortization and write-off of deferred financing costs 167 630
Bad debt expense 566 53
Changes in operating assets and liabilities:    
Accounts receivable 9,926 4,968
Prepaid expenses and other assets (576) 2,116
Payables and accrued liabilities (10,312) 9,124
Other (874) 0
Net cash provided by operating activities 7,309 49,190
Cash flows from investing activities:    
Additions to oil and gas properties (42,190) (52,227)
Additions to other property and equipment (79) (649)
Additions to restricted investments (5,031) (5,100)
Divestiture post-closing adjustment receipts 2,724 0
Proceeds from the sale of other oil and natural gas properties 0 7,796
Net cash used in investing activities (44,576) (50,180)
Cash flows from financing activities:    
Advances on Revolving Credit Facility 0 74,000
Payments on Revolving Credit Facility 0 (71,000)
Deferred financing costs (71) 0
Shares withheld for taxes (2,116) (2,010)
Net cash (used in) provided by financing activities (2,187) 990
Net change in cash and cash equivalents (39,454) 0
Cash and cash equivalents, beginning of period 60,666 0
Cash and cash equivalents, end of period $ 21,212 $ 0